The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice

References

• Ahadpour, M., et al., 2016. Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria. Drug and Chemical Toxicology, 39 (2), 224–232.
   PubMed Web of Science ®Google Scholar
• Amini-Khoei, H., et al., 2017. Oxytocin mitigated the depressive-like behaviors of maternal separation stress through modulating mitochondrial function and neuroinflammation. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 76, 169–178.
   PubMed Web of Science ®Google Scholar
• Amiri, S., et al., 2016. NMDA receptors are involved in the antidepressant-like effects of capsaicin following amphetamine withdrawal in male mice. Neuroscience, 329, 122–133.
   PubMed Web of Science ®Google Scholar
• Andalib, S., et al., 2019. Coenzyme Q 10 alleviated behavioral dysfunction and bioenergetic function in an animal model of depression. Neurochemical Research, 44 (5), 1182–1191.
   PubMed Web of Science ®Google Scholar
• Bakunina, N., Pariante, C.M., and Zunszain, P.A., 2015. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology, 144 (3), 365–373.
   PubMed Web of Science ®Google Scholar
• Barr, A.M., Markou, A., and Phillips, A.G., 2002. A ‘crash’ course on psychostimulant withdrawal as a model of depression. Trends in Pharmacological Sciences, 23 (10), 475–482.
   PubMed Web of Science ®Google Scholar
• Bhatt, S., Naik Nagappa, A., and Patil, C.R., 2020. Role of oxidative stress in depression. Drug Discovery Today, 25 (7), 1270–1276.
   PubMed Web of Science ®Google Scholar
• Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72 (1-2), 248–254.
   PubMed Web of Science ®Google Scholar
• Brand, M.D., and Nicholls, D.G., 2011. Assessing mitochondrial dysfunction in cells. Biochemical Journal, 435 (2), 297–312.
   PubMed Web of Science ®Google Scholar
• Can, A., et al., 2012. The tail suspension test. JoVE (Journal of Visualized Experiments), (59), e3769.
   Google Scholar
• Chandrasekhar Pammi, V.S., et al., 2015. Neural loss aversion differences between depression patients and healthy individuals: a functional MRI investigation. The Neuroradiology Journal, 28 (2), 97–105.
   PubMed Web of Science ®Google Scholar
• Chen, W.-J., et al., 2017. Protective effects of resveratrol on mitochondrial function in the hippocampus improves inflammation-induced depressive-like behavior. Physiology & Behavior, 182, 54–61.
   PubMed Web of Science ®Google Scholar
• Chomchai, C., and Chomchai, S., 2015. Global patterns of methamphetamine use. Current Opinion in Psychiatry, 28 (4), 269–274.
   PubMed Web of Science ®Google Scholar
• Der-Avakian, A., et al., 2014. Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response. Biological Psychiatry, 76 (7), 542–549.
   PubMed Web of Science ®Google Scholar
• Detanico, B.C., et al., 2009. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. European Journal of Pharmacology, 607 (1-3), 121–125.
   PubMed Web of Science ®Google Scholar
• Duman, R.S., 2004. Depression: a case of neuronal life and death? Biological Psychiatry, 56 (3), 140–145.
   PubMed Web of Science ®Google Scholar
• Gałecki, P., et al., 2009. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacological Reports : PR, 61 (3), 436–447.
   PubMed Web of Science ®Google Scholar
• Garrido‐Mesa, N., Zarzuelo, A., and Gálvez, J., 2013a. Minocycline: far beyond an antibiotic. British Journal of Pharmacology, 169 (2), 337–352.
   PubMed Web of Science ®Google Scholar
• Garrido-Mesa, N., Zarzuelo, A., and Gálvez, J., 2013b. What is behind the non-antibiotic properties of minocycline? Pharmacological Research, 67 (1), 18–30.
   PubMed Web of Science ®Google Scholar
• Hajheidari, S., Miladi-Gorji, H., and Bigdeli, I., 2015. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats. Neuroscience Letters, 605, 39–43.
   PubMed Web of Science ®Google Scholar
• Haj-Mirzaian, A., et al., 2018. Involvement of NO/NMDA-R pathway in the behavioral despair induced by amphetamine withdrawal. Brain Research Bulletin, 139, 81–90.
   PubMed Web of Science ®Google Scholar
• Haj-Mirzaian, A., et al., 2017. Anxiety- and depressive-like behaviors are associated with altered hippocampal energy and inflammatory status in a mouse model of Crohn’s disease. Neuroscience, 366, 124–137.
   PubMed Web of Science ®Google Scholar
• Koltunowska, D., Gibula-Bruzda, E., and Kotlinska, J.H., 2013. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 45, 242–249.
   PubMed Web of Science ®Google Scholar
• Kraus, R.L., et al., 2005. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical‐scavenging activity. Journal of Neurochemistry, 94 (3), 819–827.
   PubMed Web of Science ®Google Scholar
• Lin, M., Sambo, D., and Khoshbouei, H., 2016. Methamphetamine regulation of firing activity of dopamine neurons. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 36 (40), 10376–10391.
   PubMed Web of Science ®Google Scholar
• Mashayekhi, V., et al., 2014. Induction of mitochondrial permeability transition (MPT) pore opening and ROS formation as a mechanism for methamphetamine-induced mitochondrial toxicity'. Naunyn-Schmiedeberg’s Archives of Pharmacology, 387 (1), 47–58.
   PubMed Web of Science ®Google Scholar
• Mouton, M., et al., 2016. The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression. Metabolic Brain Disease, 31 (1), 63–74.
   PubMed Web of Science ®Google Scholar
• Newton, T.F., et al., 2009. Theories of addiction: methamphetamine users’ explanations for continuing drug use and relapse. American Journal on Addictions, 18 (4), 294–300.
   PubMed Web of Science ®Google Scholar
• Ohmori, T., et al., 1994. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacology Biochemistry and Behavior, 48 (3), 587–591.
   PubMed Web of Science ®Google Scholar
• Peng, W.-H., et al., 2007. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sciences, 81 (11), 933–938.
   PubMed Web of Science ®Google Scholar
• Pu, C., Broening, H.W., and Vorhees, C.V., 1996. Effect of methamphetamine on glutamate‐positive neurons in the adult and developing rat somatosensory cortex. Synapse, 23 (4), 328–334.
   PubMed Web of Science ®Google Scholar
• Raefsky, S.M., and Mattson, M.P., 2017. Adaptive responses of neuronal mitochondria to bioenergetic challenges: roles in neuroplasticity and disease resistance. Free Radical Biology & Medicine, 102, 203–216.
   PubMed Web of Science ®Google Scholar
• Ren, W., et al., 2017. Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal. Journal of Affective Disorders, 221, 165–171.
   PubMed Web of Science ®Google Scholar
• Sadeghi, M., Peeri, M., and Hosseini, M.-J., 2016. Adolescent voluntary exercise attenuated hippocampal innate immunity responses and depressive-like behaviors following maternal separation stress in male rats. Physiology & Behavior, 163, 177–183.
   PubMed Web of Science ®Google Scholar
• Sekine, Y., et al., 2006. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry, 63 (1), 90–100.
   PubMed Web of Science ®Google Scholar
• Sekine, Y., et al., 2003. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. American Journal of Psychiatry, 160 (9), 1699–1701.
   PubMed Web of Science ®Google Scholar
• Su, H., et al., 2017. Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal. Medicine, 96, e6434.
   PubMed Web of Science ®Google Scholar
• Szumlinski, K.K., et al., 2017. Methamphetamine addiction vulnerability: the glutamate, the bad, and the ugly. Biological Psychiatry, 81 (11), 959–970.
   PubMed Web of Science ®Google Scholar
• Valvassori, S.S., et al., 2011. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. Journal of Psychopharmacology, 25 (2), 274–280.
   PubMed Web of Science ®Google Scholar
• Wieckowski, M.R., et al., 2009. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nature Protocols, 4 (11), 1582–1590.
   PubMed Web of Science ®Google Scholar
• Winslow, B.T., Voorhees, K.I., and Pehl, K.A., 2007. Methamphetamine abuse. American Family Physician, 76 (8), 1169–1174.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2009. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Research, 1275, 87–95.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2001. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Annals of the New York Academy of Sciences, 937, 93–120.
   PubMed Web of Science ®Google Scholar
• Zorick, T., et al., 2010. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction (Abingdon, England), 105 (10), 1809–1818.
   PubMed Web of Science ®Google Scholar